However, the activation of IFN-γ receptor (IFNGR) on tumor cells can mediate the upregulation of PD-L1 through the JAK/STAT signaling pathway (Ribas et al., 2015; Garcia-Diaz et al., 2017). Here, IFNGR1 is linked to neoplasm.